eli lilly retatrutide clinical trials Phase 3 obesity trial results 2026 Medscape | Retatrutide, Eli Lilly's

It has been around since 1959, making it one of the longest-standing FDA-approved weight loss medications in the United States

Dont rush to the highest dosea sustainable and effective dose is better than the maximum dose if it means you can stick with the treatment

Ozempic & GLP-1 Weight Loss Drug Lawsuit Attorneys Home \ New York Personal Injury Lawyer \ New York Ozempic & GLP-1 Weight Loss Drug Lawsuit Attorneys John Richmond, Co-Founder and CEO June 18, 2026 Recent scientific studies and thousands of reported cases have linked popular GLP-1 receptor agonist medicationsoriginally designed for Type 2 diabetes but widely prescribed for weight lossto life-altering side effects

PloS Biol

"The math of insulin versus GLP-1 is pretty clear to a rational economic actor," Andrews said

Open questions The authors cautioned that the trial was a small pilot study and not randomized, adding that all participants had obesity